Article
SNP array analysis in hematologic malignancies: avoiding false discoveries.
Blood - 27 May 2010
Heinrichs Stefan, Li Cheng, Look A Thomas
Abstract excerpt
Comprehensive analysis of the cancer genome has become a standard approach to identifying new disease loci, and ultimately will guide therapeutic decisions. A key technology in this effort, single nucleotide polymorphism arrays, has been applied in hematologic malignancies to detect deletions, amplifications, and loss of heterozygosity (LOH) at high resolution. An inherent challenge of such studies lies in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
